We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

467 hedge funds and large institutions have $5.28B invested in Bioverativ Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 467 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more call options, than puts

Call options by funds: $21.4M | Put options by funds: $14.1M

Holders
467
Holders Change
+467
Holders Change %
–
% of All Funds
11.62%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.22%
New
467
Increased
–
Reduced
–
Closed
–
Calls
$21.4M
Puts
$14.1M
Net Calls
+$7.29M
Net Calls Change
+$7.29M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$433M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$429M
3
VH
ValueAct Holdings
California
+$418M
4
Primecap Management
Primecap Management
California
+$381M
5
HM
HealthCor Management
New York
+$246M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
MAM
276
Martingale Asset Management
Massachusetts
$290K +$262K +5,325 New
PP
277
Paloma Partners
Connecticut
$290K +$263K +5,332 New
OA
278
Oak Associates
Ohio
$289K +$262K +5,315 New
V
279
Veritable
Delaware
$285K +$258K +5,240 New
GHCM
280
Glen Harbor Capital Management
California
$284K +$257K +5,208 New
EIM
281
Essex Investment Management
Massachusetts
$282K +$255K +5,185 New
MLIC
282
Mandatum Life Insurance Company
Finland
$278K +$251K +5,102 New
WTC
283
WhitTier Trust Company
Nevada
$275K +$248K +5,043 New
MF
284
Magnetar Financial
Illinois
$273K +$247K +5,017 New
FBC
285
Fairfield, Bush & Co
Connecticut
$272K +$246K +5,000 New
TH
286
Timber Hill
Connecticut
$271K +$245K +4,974 New
JIC
287
Johnson Investment Counsel
Ohio
$266K +$241K +4,894 New
TCM
288
Traynor Capital Management
Pennsylvania
$264K +$229K +4,641 New
Fayez Sarofim & Co
289
Fayez Sarofim & Co
Texas
$264K +$239K +4,856 New
CIBC Asset Management
290
CIBC Asset Management
Ontario, Canada
$263K +$238K +4,834 New
KeyBank National Association
291
KeyBank National Association
Ohio
$261K +$236K +4,786 New
FIM
292
Fernwood Investment Management
Massachusetts
$253K +$229K +4,650 New
RCM
293
Riverhead Capital Management
Delaware
$250K +$227K +4,600 New
ECM
294
Estabrook Capital Management
New York
$245K +$222K +4,500 New
AT
295
Arden Trust
Delaware
$240K +$217K +4,410 New
Janus Henderson Group
296
Janus Henderson Group
United Kingdom
$238K +$216K +4,377 New
BRA
297
Bender Robert & Associates
California
$235K +$212K +4,311 New
LWCFA
298
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
$231K +$209K +4,241 New
CAM
299
Covenant Asset Management
New Jersey
$228K +$206K +4,182 New
CSS
300
Cubist Systematic Strategies
Connecticut
$226K +$205K +4,158 New
10 11
12
13 14

BIVV Hedge Fund Activity: Q1 2017 in Review

467 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2017, worth a combined $5.28B.

Buyers outnumbered sellers: 467 funds opened new BIVV positions and 0 closed out — a net gain of 467 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $433M.

  • 467 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $5.28B of Bioverativ Inc. Common Stock stock for Q1 2017.
  • 467 funds opened new Bioverativ Inc. Common Stock positions in Q1 2017 and 0 closed out, a net change of +467 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $433M added.

Based on aggregated 13F filings for Q1 2017.